RESMED, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.7 USD | -0.08% |
|
+2.05% | +23.03% |
Presenter SpeechLee Hambright (Analysts)We are ready to go. Thanks, everybody, for joining. I'...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-07-31
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
210.9
USD
Average target price
218.7
USD
Spread / Average Target
+3.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.03% | 30.98B | |
| +9.56% | 222B | |
| +14.29% | 195B | |
| +23.29% | 148B | |
| +33.37% | 113B | |
| +4.18% | 66.45B | |
| +12.87% | 53.11B | |
| +3.16% | 50.03B | |
| -4.16% | 38.8B | |
| -2.29% | 34.85B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Transcript : ResMed Inc. Presents at Bernstein 38th Annual Strategic Decisions Conference, Jun-01-2022 01
